Sun Pharma Advanced Research Company share news and announcements
NSE: SPARCBSE: 532872Pharmaceuticals & BiotechnologySmall Cap
Last close ₹171.77down ₹1.32 (0.76%)BSE ₹171.75
Share price at the NSE close on 23 Oct 2026. Previous close ₹173.09.
52-week range of traded prices to 23 Oct 2026
₹108.00Low, 23 Mar 2026₹289.00High, 8 Jul 2026
- Next results date: the board meets on 2 Nov 2026 to consider: financial results.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹5,574 Cr778th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 3.5
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 18 May 2026
- 4.2
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the latest balance sheet's; the one a year before is not on record. The filing of 10 Aug 2026
- 118.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 84.8%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 18 May 2026
- 0.42
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day.
- 7,97,11238.6% delivered
Sun Pharma Advanced Research Company share news and announcements
583 announcements, routine notices left out, newest first. Page 12 of 12.
May 2010
7 May · Board meeting
To consider and approve the audited financial results of the company for the year ended March 31, 2010.
Jan 2010
11 Jan · Board meeting
Meeting on 23 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
9 Oct · Board meeting
Meeting on 24 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”
Sep 2009
16 Sep · Updates
Chairman's Speech delivered at the Annual General Meeting of the Company held on September 11, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.14 Sep · Meeting
Proceedings of the Annual General Meeting of the Company held on September 11, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2009
12 Aug · Meeting
Notice of the Annual General Meeting of the Shareholders of the Company to be held on 11 September, 2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.7 Aug · Limited Review Report
Auditors have conducted the limited review for the un-audited financial results for the quarter ended June 30,2009. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2009
31 Jul · Corporate action
Register of Members and Share Transfer Books of the Company will be closed from August 25, 2009 to September 5, 2009 (Both days inclusive) for the purpose of holding of Annual General Meeting of the Company to be held on September 11, 2009.7 Jul · Board meeting
Meeting on 20 Jul 2009: “Unaudited Financial Results for the Qtr ended June 30, 2009”
May 2009
12 May · Board meeting
Interalia, to consider the audited financial results of the Company for the year ended March 31, 2009.
Apr 2009
21 Apr · Results
The Company shall be publishing the Audited Annual Accounts/Results for the year ended 31st March, 2009 within the stipulated time period of three months from the closure of the financial year i.e. by 30th June, 2009. Accordingly, the un-audited financial results for the fourth quarter / year ended 31st March, 2009 will not be published by the Company
Jan 2009
24 Jan · Change in Company Secretary
Board of Directors of the Company at its meeting held on January 24, 2009 accepted the resignation of Shri Sunil R. Ajmera as Company Secretary of the Company w.e.f. February 01, 2009 and the Board appointed Ms. Meetal S. Sampat as the Company Secretary of the Company w.e.f. February 01, 2009.13 Jan · Board meeting
Meeting on 24 Jan 2009: “Unaudited Financial Results for the qtr ended Dec 31, 2008”
Oct 2008
15 Oct · Board meeting
Interalia, to consider and take on record the un-audited financial results of the Company for the half year / second quarter ended September 30, 2008.
Sep 2008
8 Sep · Meeting
Proceedings of the Annual General Meeting of the Company held on September 06, 2008. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Jul 2008
23 Jul · Meeting
Register of members and Share Transfer Books of the Company will be closed from August 27, 2008 to September 06, 2008 (both days inclusive) for the purpose of holding of Annual General Meeting of the Company to be held on September 06, 2008.14 Jul · Board meeting
Meeting on 29 Jul 2008: “Unaudited Financial Results for the Qtr ended June 30, 2008”
Apr 2008
28 Apr · Board meeting
Interalia, to consider the audited financial results of the Company for the year ended March 31, 2008.
Mar 2008
24 Mar · Allotment of Equity Shares
Vide its letter dated March 20, 2008, that: "Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds of US $ 1000 each (FCCBs) held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held today on March 20, 2008 has allotted 25,18,834 (Twenty Five Lakhs Eighteen Thousand Eight Hundred and Thirty Four) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 40,813 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,45,97,557 Equity Shares of Re. 1/- each to 20,71,16,391 Equity Shares of Re. 1/- each, as of date. Further the Company has informed that the entire 350,000 Zero Coupon Foreign Currency Convertible Bonds, due 2009 of US$ 1,000/- each, issued by Sun Pharmaceuticals Industries Ltd., have been converted. After the above allotment there are no FCCBs remaining outstanding".3 Mar · Allotment of Equity Shares
Vide its letter dated March 01, 2008, that: "Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on March 1, 2008 has allotted 31,20,084 (Thirty One Lacs Twenty Thousand Eighty Four) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 50,555 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,14,77,473 Equity Shares of Re. 1/- each to 20,45,97,557 Equity Shares of Re. 1/- each, as of date".
Jan 2008
25 Jan · Allotment of Equity Shares
Vide its letter dated January 25, 2008, that: "Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on January 25, 2008 has allotted 30,858 (Thirty Thousand Eight Hundred and Fifty Eight) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,14,46,615 Equity Shares of Re. 1/- each to 20,14,77,473 Equity Shares of Re. 1/- each, as of date".8 Jan · Board meeting
Meeting on 24 Jan 2008: “Unaudited Financial Results for the qtr ended Dec 31, 2007”
Dec 2007
31 Dec · Allotment of Equity Shares
Vide its letter dated December 29, 2007, that: "Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on December 29, 2007 has allotted 3,39,439 (Three Lakhs Thirty Nine Thousand Four Hundred and Thirty Nine) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 5,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,11,07,176 Equity Shares of Re. 1/- each to 20,14,46,615 Equity Shares of Re. 1/- each, as of date".4 Dec · Allotment of Equity Shares
Vide its letter dated December 01, 2007 that: "Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on December 1, 2007 has allotted 2,08,599 (Two Lakhs Eight Thousand Five Hundred Ninety Nine) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 3,380 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,08,98,577 Equity Shares of Re. 1/- each to 20,11,07,176 Equity Shares of Re. 1/- each, as of date"
Nov 2007
5 Nov · Allotment of Equity Shares
Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on November 3, 2007 has allotted 5,09,161 (Five Lakhs Nine thousand One Hundred and Sixty One) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 8,250 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 20,03,89,416 Equity Shares of Re. 1/- each to 20,08,98,577 Equity Shares of Re. 1/- each, as of date
Oct 2007
22 Oct · Allotment of Equity Shares
Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on October 20, 2007 has allotted 8,64,034 (Eight Lakhs Sixty Four Thousand and Thirty Four) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 14,000 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 19,95,25,382 Equity Shares of Re. 1/- each to 20,03,89,416 Equity Shares of Re. 1/- each, as of date19 Oct · Allotment of Equity Shares
Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held on October 14, 2007 has allotted 3,39,441 (Three Lakhs Thirty Nine Thousand Four Hundred and Forty One) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 5,500 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 19,91,85,941 Equity Shares of Re. 1/- each to 19,95,25,382 Equity Shares of Re. 1/- each, as of date9 Oct · Board meeting
Interalia, to consider and take on record the un-audited financial results of the Company for the half year / second quarter ended September 30, 2007.
Sep 2007
7 Sep · Meeting
Report of Proceedings of Annual General Meeting of the Company held on September 05, 2007. A copy of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Aug 2007
13 Aug · Allotment of shares
Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High Court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond Holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re. 1/- each of the Company for every Equity Share of Rs. 5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US $ 1000 each held by them. Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held today August 11, 2007 has allotted 1,247,972 (One Million Two Hundred Forty Seven Thousand Nine Hundred and Seventy two) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 20,221 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 19,79,37,969 Equity Shares of Re. 1/- each to 19,91,85,941 Equity Shares of Re. 1/- each, as of date9 Aug · Meeting
The Register of members and Share Transfer Books of the Company in respect of Equity Shares will remain closed from Thursday, August 30, 2007 to Wednesday, September 5, 2007 (both days inclusive) for the purpose of Second Annual General Meeting of the Company to be held on 5th September, 2007
Jul 2007
23 Jul · Allotment of Equity Shares
Pursuant to clause 10.2 of the Scheme of Arrangement for Demerger sanctioned by the Honourable High court of Gujarat vide its order dated 01.03.2007 issued on 28.03.2007 and as per the Supplementary Trust Deed dated 18.05.2007, entered into by the Company with Sun Pharmaceutical Industries Ltd. and Citicorp Trustee Co. Ltd., the Foreign Currency Convertible Bond holders of Sun Pharmaceutical Industries Ltd. (SPIL), are entitled to One Equity Share of Re.1/- each of the Company for every Equity Share of Rs.5/- each of SPIL allotted to them on exercise of conversion option of Foreign Currency Convertible Bonds (FCCBs) of US$1000 each held by them.Accordingly, the Committee of Directors (Allotment) of the Company at its meeting held today, July 21, 2007 has allotted 842,430 (Eight Hundred Forty Two Thousand Four Hundred And Thirty) Equity Shares of Re.1/- each to the bondholders of SPIL upon exercise of option of conversion for 13,650 Zero Coupon Foreign Currency Convertible Bonds of US $ 1000 each (FCCB) of SPIL held by them. Consequently, the paid up Equity Share Capital of the Company has increased from 19,70,95,539 Equity Shares of Re. 1/- each to 19,79,37,969 Equity Shares of Re. 1/- each, as of date18 Jul · Board meeting
Meeting on 23 Jul 2007: “Unaudited financial results for quarter ended June 30, 2007”